Teva Pharmaceutical Industries Ltd. (TEVA)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 5 |
| Ownership rank: | 91 |
| % of all portfolios: | 0.053% |
| Hold Price * : | $16.25 |
| History |
Portfolio Manager |
Activity |
Share change |
% change to portfolio ▼ |
| Q3 2013 |
| ≡ |
David Katz - Matrix Asset Advisors |
Add 20.00% |
9,000 |
0.48 |
| ≡ |
Thomas Gayner - Markel Group |
Add 0.14% |
1,000 |
0.00 |
| Q2 2013 |
| ≡ |
Harry Burn - Sound Shore |
Sell 100.00% |
401,300 |
1.01 |
| ≡ |
Thomas Gayner - Markel Group |
Add 5.33% |
35,400 |
0.05 |
| Q1 2013 |
| ≡ |
Harry Burn - Sound Shore |
Buy |
401,300 |
1.01 |
| ≡ |
Thomas Gayner - Markel Group |
Add 3.03% |
19,500 |
0.03 |
| Q4 2012 |
| ≡ |
David Katz - Matrix Asset Advisors |
Reduce 3.23% |
1,500 |
0.11 |
| ≡ |
Thomas Gayner - Markel Group |
Add 8.12% |
48,400 |
0.08 |
| Q3 2012 |
| ≡ |
David Katz - Matrix Asset Advisors |
Reduce 16.96% |
9,500 |
0.68 |
| ≡ |
Thomas Gayner - Markel Group |
Add 7.62% |
42,200 |
0.07 |
| Q2 2012 |
| ≡ |
David Rolfe - Wedgewood Partners |
Sell 100.00% |
1,177,319 |
4.29 |
| ≡ |
David Katz - Matrix Asset Advisors |
Add 40.00% |
16,000 |
0.84 |
| ≡ |
Thomas Gayner - Markel Group |
Add 3.15% |
16,900 |
0.03 |
| Q1 2012 |
| ≡ |
David Rolfe - Wedgewood Partners |
Add 37.06% |
318,337 |
1.16 |
| ≡ |
David Katz - Matrix Asset Advisors |
Add 37.93% |
11,000 |
0.59 |
| ≡ |
Thomas Gayner - Markel Group |
Add 14.63% |
68,500 |
0.14 |
| Q4 2011 |
| ≡ |
Thomas Gayner - Markel Group |
Add 38.41% |
129,900 |
0.28 |
| ≡ |
David Katz - Matrix Asset Advisors |
Add 9.43% |
2,500 |
0.13 |
| Q3 2011 |
| ≡ |
Thomas Gayner - Markel Group |
Add 34.15% |
86,100 |
0.20 |
| ≡ |
David Katz - Matrix Asset Advisors |
Add 10.42% |
2,500 |
0.13 |
| Q2 2011 |
| ≡ |
David Katz - Matrix Asset Advisors |
Buy |
24,000 |
1.19 |
| ≡ |
Thomas Gayner - Markel Group |
Add 76.79% |
109,500 |
0.28 |
| Q1 2011 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Sell 100.00% |
177,400 |
0.07 |
| ≡ |
Thomas Gayner - Markel Group |
Add 17.27% |
21,000 |
0.06 |
| Q4 2010 |
| ≡ |
Thomas Gayner - Markel Group |
Add 35.87% |
32,100 |
0.09 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Buy |
177,400 |
0.07 |
| Q3 2010 |
| ≡ |
Thomas Gayner - Markel Group |
Add 48.67% |
29,300 |
0.09 |
| Q2 2010 |
| ≡ |
Thomas Gayner - Markel Group |
Add 0.50% |
300 |
0.00 |
| Q1 2010 |
| ≡ |
Thomas Gayner - Markel Group |
Buy |
59,900 |
0.23 |
| Q2 2009 |
| ≡ |
Bill & Melinda Gates Foundation Trust |
Sell 100.00% |
277,595 |
0.15 |
| Q1 2008 |
| ≡ |
David Katz - Matrix Asset Advisors |
Sell 100.00% |
108,000 |
3.13 |
| Q4 2007 |
| ≡ |
David Katz - Matrix Asset Advisors |
Reduce 30.10% |
46,500 |
1.35 |
| Q3 2007 |
| ≡ |
David Katz - Matrix Asset Advisors |
Reduce 20.77% |
40,500 |
0.88 |
| ≡ |
Bill & Melinda Gates Foundation Trust |
Buy |
277,595 |
0.14 |
| Q2 2007 |
| ≡ |
David Katz - Matrix Asset Advisors |
Add 2.09% |
4,000 |
0.07 |
| Q1 2007 |
| ≡ |
David Katz - Matrix Asset Advisors |
Reduce 4.98% |
10,000 |
0.20 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.